Low-dose aprotinin infusion is not clinically useful to reduce bleeding and transfusion of homologous blood products in high-risk cardiac surgical patients
Open Access
- 1 July 1993
- journal article
- clinical trial
- Published by Springer Nature in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Vol. 40 (7) , 625-631
- https://doi.org/10.1007/bf03009699
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Natural and synthetic antifibrinolytics in cardiac surgeryCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1992
- Blood Conservation Techniques and Platelet Function in Cardiac SurgeryAnesthesiology, 1991
- LOW DOSE APROTININ OR TRANEXANIC ACID TREATMENT IN CARDIAC SURGERYAnesthesiology, 1991
- High-Dose Aprotinin: Hemostatic Effects in Open Heart OperationsThe Annals of Thoracic Surgery, 1989
- Reduction of Homologous Blood Requirement in Cardiac Surgery by Intraoperative Aprotinin Application - Clinical Experience in 152 Cardiac Surgical PatientsThe Thoracic and Cardiovascular Surgeon, 1989
- Reduction of Blood Transfusion Requirement in Open Heart Surgery by Administration of High Doses of Aprotinin - Preliminary ResultsThe Thoracic and Cardiovascular Surgeon, 1989
- Effects of Aprotinin on Hemostatic Mechanisms during Cardiopulmonary BypassThe Annals of Thoracic Surgery, 1987
- Clinical Application of Inhibitors of FibrinolysisDrugs, 1985
- Collagenous sprue.BMJ, 1971
- NATURAL PROTEINASE INHIBITORS IN EXTRACORPOREAL CIRCULATIONAnnals of the New York Academy of Sciences, 1968